A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- PMID: 29224780
- DOI: 10.1016/j.cell.2017.11.010
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Abstract
Breast cancer (BC) comprises multiple distinct subtypes that differ genetically, pathologically, and clinically. Here, we describe a robust protocol for long-term culturing of human mammary epithelial organoids. Using this protocol, >100 primary and metastatic BC organoid lines were generated, broadly recapitulating the diversity of the disease. BC organoid morphologies typically matched the histopathology, hormone receptor status, and HER2 status of the original tumor. DNA copy number variations as well as sequence changes were consistent within tumor-organoid pairs and largely retained even after extended passaging. BC organoids furthermore populated all major gene-expression-based classification groups and allowed in vitro drug screens that were consistent with in vivo xeno-transplantations and patient response. This study describes a representative collection of well-characterized BC organoids available for cancer research and drug development, as well as a strategy to assess in vitro drug response in a personalized fashion.
Keywords: basal; biobank; breast cancer; luminal; organoids; precision medicine; triple negative.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment in
-
Organoid Models of Cancer Explode with Possibilities.Cell Stem Cell. 2018 Mar 1;22(3):290-291. doi: 10.1016/j.stem.2018.02.010. Cell Stem Cell. 2018. PMID: 29499146
Similar articles
-
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.Nat Commun. 2020 Mar 11;11(1):1310. doi: 10.1038/s41467-020-15155-6. Nat Commun. 2020. PMID: 32161258 Free PMC article.
-
Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.In Vitro Cell Dev Biol Anim. 2021 May;57(5):510-518. doi: 10.1007/s11626-021-00563-9. Epub 2021 May 5. In Vitro Cell Dev Biol Anim. 2021. PMID: 33950403
-
Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.Gynecol Oncol. 2019 Jul;154(1):189-198. doi: 10.1016/j.ygyno.2019.05.005. Epub 2019 May 14. Gynecol Oncol. 2019. PMID: 31101504
-
Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.Cells. 2019 May 17;8(5):470. doi: 10.3390/cells8050470. Cells. 2019. PMID: 31108870 Free PMC article. Review.
-
Functional Optical Imaging of Primary Human Tumor Organoids: Development of a Personalized Drug Screen.J Nucl Med. 2017 Sep;58(9):1367-1372. doi: 10.2967/jnumed.117.192534. Epub 2017 Jun 6. J Nucl Med. 2017. PMID: 28588148 Review.
Cited by
-
Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids.Front Oncol. 2024 Oct 14;14:1470379. doi: 10.3389/fonc.2024.1470379. eCollection 2024. Front Oncol. 2024. PMID: 39469640 Free PMC article.
-
Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids.Cancer Lett. 2024 Aug 28;598:217106. doi: 10.1016/j.canlet.2024.217106. Epub 2024 Jul 9. Cancer Lett. 2024. PMID: 38992487 Free PMC article.
-
Precision Immunotherapy Utilizing Adapter CAR-T Cells (AdCAR-T) in Metastatic Breast Cancer Leads to Target Specific Lysis.Cancers (Basel). 2023 Dec 29;16(1):168. doi: 10.3390/cancers16010168. Cancers (Basel). 2023. PMID: 38201595 Free PMC article.
-
In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy.Explor Target Antitumor Ther. 2022;3(3):297-320. doi: 10.37349/etat.2022.00084. Epub 2022 Jun 1. Explor Target Antitumor Ther. 2022. PMID: 36045910 Free PMC article. Review.
-
Biobanks-A Platform for Scientific and Biomedical Research.Diagnostics (Basel). 2020 Jul 16;10(7):485. doi: 10.3390/diagnostics10070485. Diagnostics (Basel). 2020. PMID: 32708805 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous